Ran (RAs-related Nuclear protein) also known as GTP-binding nuclear protein Ran is a
protein that in humans is encoded by the RAN
gene. Ran is a small 25 kDa protein that is involved in transport into and out of the
cell nucleus during
interphase and also involved in
mitosis. It is a member of the
Ras superfamily.[5][6][7]
Ran is a
small G protein that is essential for the translocation of RNA and proteins through the
nuclear pore complex. The Ran protein has also been implicated in the control of DNA synthesis and cell cycle progression, as mutations in Ran have been found to disrupt DNA synthesis.[8]
Function
Ran cycle
Ran exists in the cell in two nucleotide-bound forms:
GDP-bound and
GTP-bound. RanGDP is converted into RanGTP through the action of
RCC1, the
nucleotide exchange factor for Ran. RCC1 is also known as RanGEF (Ran Guanine nucleotide Exchange Factor). Ran's intrinsic
GTPase-activity is activated through interaction with Ran
GTPase activating protein (RanGAP), facilitated by complex formation with Ran-binding protein (RanBP). GTPase-activation leads to the conversion of RanGTP to RanGDP, thus closing the Ran cycle.
Ran can diffuse freely within the cell, but because RCC1 and RanGAP are located in different places in the cell, the concentration of RanGTP and RanGDP differs locally as well, creating concentration gradients that act as signals for other cellular processes. RCC1 is bound to
chromatin and therefore located inside the
nucleus. RanGAP is
cytoplasmic in yeast and bound to the
nuclear envelope in plants and animals. In mammalian cells, it is
SUMO modified and attached to the cytoplasmic side of the
nuclear pore complex via interaction with the
nucleoporinRANBP2 (Nup358). This difference in location of the accessory proteins in the Ran cycle leads to a high RanGTP to RanGDP ratio inside the nucleus and an inversely low RanGTP to RanGDP ratio outside the nucleus. In addition to a gradient of the nucleotide bound state of Ran, there is a gradient of the protein itself, with a higher concentration of Ran in the nucleus than in the cytoplasm. Cytoplasmic RanGDP is imported into the nucleus by the small protein
NUTF2 (Nuclear Transport Factor 2), where RCC1 can then catalyze exchange of GDP for GTP on Ran.
Role in nuclear transport during interphase
Ran is involved in the transport of proteins across the nuclear envelope by interacting with
karyopherins and changing their ability to bind or release cargo molecules. Cargo proteins containing a
nuclear localization signal (NLS) are bound by
importins and transported into the nucleus. Inside the nucleus, RanGTP binds to importin and releases the import cargo. Cargo that needs to get out of the nucleus into the cytoplasm binds to
exportin in a ternary complex with RanGTP. Upon hydrolysis of RanGTP to RanGDP outside the nucleus, the complex dissociates and export cargo is released.
Role in mitosis
During mitosis, the Ran cycle is involved in
mitotic spindle assembly and nuclear envelope reassembly after the chromosomes have been separated.[9][10] During
prophase, the steep gradient in RanGTP-RanGDP ratio at the nuclear pores breaks down as the nuclear envelope becomes leaky and disassembles. RanGTP concentration stays high around the
chromosomes as RCC1, a nucleotide exchange factor, stays attached to
chromatin.[11] RanBP2 (Nup358) and RanGAP move to the
kinetochores where they facilitate the attachment of spindle fibers to chromosomes. Moreover, RanGTP promotes spindle assembly by mechanisms similar to mechanisms of nuclear transport: the activity of spindle assembly factors such as
NuMA and
TPX2 is inhibited by the binding to importins. By releasing importins, RanGTP activates these factors and therefore promotes the assembly of the
mitotic spindle. In
telophase, RanGTP hydrolysis and nucleotide exchange are required for
vesicle fusion at the reforming nuclear envelopes of the daughter nuclei.
Ran and the androgen receptor
RAN is an
androgen receptor (AR)
coactivator (ARA24) that binds differentially with different lengths of
polyglutamine within the androgen receptor. Polyglutamine repeat expansion in the AR is linked to
spinal and bulbar muscular atrophy (Kennedy's disease). RAN coactivation of the AR diminishes with polyglutamine expansion within the AR, and this weak coactivation may lead to partial androgen insensitivity during the development of spinal and bulbar muscular atrophy.[12][13]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Moore MS, Blobel G (May 1994). "A G protein involved in nucleocytoplasmic transport: the role of Ran". Trends Biochem. Sci. 19 (5): 211–6.
doi:
10.1016/0968-0004(94)90024-8.
PMID7519373.
^Carazo-Salas RE, Guarguaglini G, Gruss OJ, Segref A, Karsenti E, Mattaj IW (July 1999). "Generation of GTP-bound Ran by RCC1 is required for chromatin-induced mitotic spindle formation". Nature. 400 (6740): 178–81.
Bibcode:
1999Natur.400..178C.
doi:
10.1038/22133.
PMID10408446.
S2CID4417176.
^Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C (2001). "Identification and characterization of androgen receptor associated coregulators in prostate cancer cells". J. Biol. Regul. Homeost. Agents. 15 (2): 123–9.
PMID11501969.
^Percipalle P, Clarkson WD, Kent HM, Rhodes D, Stewart M (1997). "Molecular interactions between the importin alpha/beta heterodimer and proteins involved in vertebrate nuclear protein import". J. Mol. Biol. 266 (4): 722–32.
doi:
10.1006/jmbi.1996.0801.
PMID9102465.
^Cushman I, Bowman BR, Sowa ME, Lichtarge O, Quiocho FA, Moore MS (2004). "Computational and biochemical identification of a nuclear pore complex binding site on the nuclear transport carrier NTF2". J. Mol. Biol. 344 (2): 303–10.
doi:
10.1016/j.jmb.2004.09.043.
PMID15522285.
^Stewart M, Kent HM, McCoy AJ (1998). "Structural basis for molecular recognition between nuclear transport factor 2 (NTF2) and the GDP-bound form of the Ras-family GTPase Ran". J. Mol. Biol. 277 (3): 635–46.
doi:
10.1006/jmbi.1997.1602.
PMID9533885.
^Azuma Y, Renault L, García-Ranea JA, Valencia A, Nishimoto T, Wittinghofer A (1999). "Model of the ran-RCC1 interaction using biochemical and docking experiments". J. Mol. Biol. 289 (4): 1119–30.
doi:
10.1006/jmbi.1999.2820.
PMID10369786.